Short report: Blood stage of plasmodium vivax in central china is still susceptible to chloroquine plus primaquine combination therapy

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 1, 2013, Pages 184-187

  Zhu, Guoding ^a,b   Lu, Feng ^a,b   Cao, Jun ^a,b   Zhou, Huayun ^a,b   Liu, Yaobao ^a,b   Han, Eun Taek ^a,b   Gao, Qi ^a,b  

^a BEIJING HOSPITAL   (China)

^b Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE PLUS PRIMAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; PRIMAQUINE;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; CHINA; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD; SENTINEL SURVEILLANCE;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHINA; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; SENTINEL SURVEILLANCE; YOUNG ADULT;

EID: 84880583005     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0683     Document Type: Article

References (17)

1. WHO, 2011. World Malaria Report 2011. Available at: Http://www .who.int/malaria/world-malaria-report-2011/9789241564403-eng.pdf. Accessed February 2012.
2. Tang YE, Zhong CY, Jiang CB, Wang WM, 2011. Results of surveillance ofmalaria in Suining County. China TropMed 11: 50-51.
3. Zhang W, Wang L, Fang L, Ma J, Xu Y, Jiang J, Hui F, Wang J, Liang S, Yang H, Cao W, 2008. Spatial analysis of malaria in Anhui province, China. Malar J 7: 206.
4. Zhou SS, Wang Y, Tang LH, 2007. Malaria situation in the People's Republic of China in 2006. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 25: 439-441.
5. The Ministry of Health of the People's Republic of China, 2010. China Action Plan for Malaria Elimination. Available at: Http://www.moh.gov.cn/ publicfiles/business/htmlfiles/mohjbyfkzj/s3593/201005/47529.htm.AccessedMay 2010.
6. Baird JK, 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075-4083.
7. Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Menard D, 2008. Plasmodium vivax resistance to chloroquine in Madagascar: Clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother 52: 4233-4240.
8. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG, 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 1125-1126.
9. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
10. Zhou SS, Huang F, Wang JJ, Zhang SS, Su YP, Tang LH, 2010. Geographical, meteorological and vectorial factors related to malaria re-emergence in Huang-Huai River of central China. Malar J 9: 337.
11. WhiteNJ, 2011.Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 10: 297.
12. Editorial Committee of Malaria Control and Research in China, 1991. Malaria Control and Research in China. Beijing, China: People's Medical Publishing House.
13. Lu F, Gao Q, Zhou H, Cao J, Wang W, Lim CS, Na S, Tsuboi T, Han ET, 2012. Molecular test for vivax malaria with loop-mediated isothermal amplification method in central China. Parasitol Res 110: 2439-2444.
14. Anstey NM, Russell B, Yeo TW, Price RN, 2009. The pathophysiology of vivax malaria. Trends Parasitol 25: 220-227.
15. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
16. Lu F, Wang B, Cao J, Sattabongkot J, Zhou H, Zhu G, Kim K, Gao Q, Han E, 2012. Prevalence of drug resistance-associated gene mutations of Plasmodium vivax in Central China. Korean J Parasitol 50: 379-384.
17. Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J, 2011. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Am J Trop Med Hyg 85: 197-201.